172 related articles for article (PubMed ID: 35776338)
1. Apatinib Through Activating the RhoA/ROCK Signaling Pathway to Cause Dysfunction of Vascular Smooth Muscle Cells.
Wang W; He Q; Zhuang C; Zhang H; Fan X; Wang Q; Qi M; Sun R; Li C; Yu J
Appl Biochem Biotechnol; 2022 Nov; 194(11):5367-5385. PubMed ID: 35776338
[TBL] [Abstract][Full Text] [Related]
2. Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer.
Wang W; He Q; Li C; Zhuang C; Zhang H; Wang Q; Fan X; Qi M; Sun R; Yu J
Front Cardiovasc Med; 2022; 9():873829. PubMed ID: 35811723
[TBL] [Abstract][Full Text] [Related]
3. Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension.
Li C; Ma L; Wang Q; Shao X; Guo L; Chen J; Wang W; Yu J
J Hypertens; 2022 Apr; 40(4):675-684. PubMed ID: 34862331
[TBL] [Abstract][Full Text] [Related]
4. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
5. Rho/ROCK signal cascade mediates asymmetric dimethylarginine-induced vascular smooth muscle cells migration and phenotype change.
Zhou YM; Lan X; Guo HB; Zhang Y; Ma L; Cao JB
Biomed Res Int; 2014; 2014():683707. PubMed ID: 25121106
[TBL] [Abstract][Full Text] [Related]
6. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
8. The Lbc Rho guanine nucleotide exchange factor α-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation.
Bear MD; Li M; Liu Y; Giel-Moloney MA; Fanburg BL; Toksoz D
J Biol Chem; 2010 Oct; 285(43):32919-32926. PubMed ID: 20696764
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
10. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.
Pang H; Guo Z; Su W; Xie Z; Eto M; Gong MC
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C352-60. PubMed ID: 15814590
[TBL] [Abstract][Full Text] [Related]
11. BK
Wu Y; Yue Z; Wang Q; Lv Q; Liu H; Bai Y; Li S; Xie M; Bao J; Ma J; Wang Z; Zhu X
FASEB J; 2019 Dec; 33(12):13358-13366. PubMed ID: 31530101
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-141 Inhibits the Proliferation of Penile Cavernous Smooth Muscle Cells Associated with Down-Regulation of the Rhoa/Rho Kinase Signaling Pathway.
Zhang Y; Jia L; Ji W; Li H
Cell Physiol Biochem; 2018; 48(1):348-360. PubMed ID: 30016773
[TBL] [Abstract][Full Text] [Related]
13. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
Pagiatakis C; Gordon JW; Ehyai S; McDermott JC
J Biol Chem; 2012 Mar; 287(11):8361-70. PubMed ID: 22275376
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
15. RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC).
Chen NX; Chen X; O'Neill KD; Atkinson SJ; Moe SM
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F674-80. PubMed ID: 20610533
[TBL] [Abstract][Full Text] [Related]
16. CFTR deficiency aggravates Ang II induced vasoconstriction and hypertension by regulating Ca2+ influx and RhoA/Rock pathway in VSMCs.
Zhao L; Yuan F; Pan N; Yu Y; Yang H; Liu Y; Wang R; Zhang B; Wang G
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1396-1410. PubMed ID: 34994155
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor 9-Dependent AMPK
McCarthy CG; Wenceslau CF; Ogbi S; Szasz T; Webb RC
J Pharmacol Exp Ther; 2018 Apr; 365(1):60-71. PubMed ID: 29348267
[TBL] [Abstract][Full Text] [Related]
18. Rho kinase and hypertension.
Wirth A
Biochim Biophys Acta; 2010 Dec; 1802(12):1276-84. PubMed ID: 20460153
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
20. Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by attenuating Ca
Jadeja RN; Thounaojam MC; Bartoli M; Khurana S
Toxicol Appl Pharmacol; 2018 Jun; 348():14-21. PubMed ID: 29660437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
